MyFinsight
Home
About
Contact
zntl: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, ZNTL has $327,250K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Subscribe for Financial Insights
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
327,250
351,707
Total stockholders equity
252,874
274,495
Total liabilities and stockholders equity
327,250
351,707
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Subscribe for Financial Insights
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Prepaid expenses and
other current assets
$7,605K
Marketable equity
securities
$2,406K
Marketable securities,
available-for-sale
$239,219K
Cash and cash
equivalents
$39,072K
Restricted cash
$2,627K
Prepaid expenses and
other assets
$3,206K
Operating
leaseright-of-useassets
$30,188K
Property and equipment,
net
$2,927K
Total current assets
$288,302K
Total assets
$327,250K
Total liabilities and
stockholders equity
$327,250K
Total stockholders
equity
$252,874K
Total liabilities
$74,376K
Accumulated deficit
-$1,156,239K
Accumulated other
comprehensive income
$186K
Additional paid-in capital
$1,408,855K
Other long-term
liabilities
$500K
Long-term lease liability
$36,708K
Total current
liabilities
$37,168K
Common stock, 0.001 par
value 250,000,000...
$72K
Accrued expenses
$30,137K
Accounts payable
$7,031K
Buy me a coffee
Zentalis Pharmaceuticals, Inc. (ZNTL)
Zentalis Pharmaceuticals, Inc. (ZNTL)